We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CGIX market cap is 27.3M. The company's latest EPS is USD -3.8315 and P/E is -0.07.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 165k | 152k | 46k | 80k | 119k |
| Operating Income | -4.34M | -3.68M | -3.5M | -4.4M | -1.67M |
| Net Income | -5.81M | -3.46M | -4.26M | -4.48M | -1.63M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 27.47M | 7.31M | 5.75M | 1.15M | 666k |
| Operating Income | -21.98M | -5.7M | -8.18M | -15.71M | -15.91M |
| Net Income | -20.37M | -6.71M | -8M | -40.86M | -22.69M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 26.81M | 23.04M | 15.21M | 9.18M | 6.23M |
| Total Liabilities | 10.02M | 9.2M | 5.3M | 3.1M | 1.73M |
| Total Equity | 16.79M | 13.84M | 9.91M | 6.08M | 4.5M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 35.41M | 14.9M | 8.35M | 37.64M | 15.21M |
| Total Liabilities | 28.6M | 7.52M | 4.37M | 6.35M | 5.3M |
| Total Equity | 6.8M | 7.39M | 3.98M | 31.29M | 9.91M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -8.14M | -10.39M | -13.68M | -5.61M | -7.42M |
| Investing | -433k | -684k | 3.26M | 58k | 58k |
| Financing | -338k | -141k | -149k | 369k | 116k |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -12.55M | -8.66M | -5.37M | -16.99M | -13.68M |
| Investing | 1.08M | 9.09M | 1.01M | 29.62M | 3.26M |
| Financing | 2.15M | 3.31M | 2.64M | 7.19M | -149k |
| Market Cap | 27.3M |
| Price to Earnings Ratio | -0.07 |
| Price to Sales Ratio | 2.31 |
| Price to Cash Ratio | 0.15 |
| Price to Book Ratio | 0.16 |
| Dividend Yield | - |
| Shares Outstanding | 5.92M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.07 (1.51%) |
| Company Name | Cancer Genetics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.vyantbio.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
